NCT01649375 - 16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis | Biotech Hunter

Enrollment

219

Participants

Timeline

Start Date

October 18, 2012

Primary Completion Date

August 4, 2014

Study Completion Date

September 18, 2018

Conditions

Anklyosing Spondylitis

Interventions

DRUG

Secukinumab (75 mg)

Secukinumab 75 mg s.c.

DRUG

Placebo

DRUG

Secukinumab (150 mg)

Secukinumab 150 mg s.c.

Trial Locations (53)

1100

Novartis Investigative Site, Vienna

1708

Novartis Investigative Site, Fribourg

4031

Novartis Investigative Site, Basel

8036

Novartis Investigative Site, Graz

10128

Novartis Investigative Site, Torino

12203

Novartis Investigative Site, Berlin

15006

Novartis Investigative Site, A Coruña

16635

Novartis Investigative Site, Duncansville

28009

Novartis Investigative Site, Madrid

28046

Novartis Investigative Site, Madrid

29460

Novartis Investigative Site, Charleston

37134

Novartis Investigative Site, Verona

37909

Novartis Investigative Site, Knoxville

38801

Novartis Investigative Site, Tupelo

39008

Novartis Investigative Site, Santander

40620

Novartis Investigative Site, Jyväskylä

44649

Novartis Investigative Site, Herne

55435

Novartis Investigative Site, Edina

60200

Novartis Investigative Site, Seinäjoki

73102

Novartis Investigative Site, Oklahoma City

73103

Novartis Investigative Site, Oklahoma City

75150

Novartis Investigative Site, Mesquite

85202

Novartis Investigative Site, Mesa

91786

Novartis Investigative Site, Upland

95100

Novartis Investigative Site, Catania

97080

Novartis Investigative Site, Würzburg

115522

Novartis Investigative Site, Moscow

119074

Novartis Investigative Site, Singapore

141060

Novartis Investigative Site, Korolyov

150003

Novartis Investigative Site, Yaroslavl

169608

Novartis Investigative Site, Singapore

185019

Novartis Investigative Site, Petrozavodsk

190068

Novartis Investigative Site, Saint Petersburg

197022

Novartis Investigative Site, Saint Petersburg

620028

Novartis Investigative Site, Yekaterinburg

R3A 1M3

Novartis Investigative Site, Winnipeg

H9R 3J1

Novartis Investigative Site, Pointe-Claire

G1W 4R4

Novartis Investigative Site, Québec

G1V 3M7

Novartis Investigative Site, Sainte-Foy

792 01

Novartis Investigative Site, Bruntál

772 00

Novartis Investigative Site, Ostrava

128 50

Novartis Investigative Site, Prague

686 01

Novartis Investigative Site, Uherské Hradiště

00029

Novartis Investigative Site, HUS

FI 00100

Novartis Investigative Site, Helsinki

05800

Novartis Investigative Site, Hyvinkää

3508 GA

Novartis Investigative Site, Utrecht

1105 AZ

Novartis Investigative Site, Amsterdam

CH 8091

Novartis Investigative Site, Zurich

E11 1NR

Novartis Investigative Site, Leytonstone

LS7 4SA

Novartis Investigative Site, Leeds

NR4 7UY

Novartis Investigative Site, Norwich

TQ2 7AA

Novartis Investigative Site, Torquay